SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-040981
Filing Date
2019-07-03
Accepted
2019-07-03 15:33:57
Documents
1
Period of Report
2019-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3862
  Complete submission text file 0001209191-19-040981.txt   5324
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Issuer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 175 CASSIA WAY, SUITE 115 HENDERSON NV 89014
Business Address
Rueckert William Dodge (Reporting) CIK: 0001380016 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50484 | Film No.: 19941743